Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05419713 · ClinicalTrials.gov registry record · NA

Intermediate Visual Space Perception

A NA study of Vision, sponsored by University of Louisville.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT05419713 is a NA study of Vision that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 180 participants, below the 2,058-participant average among 5 other Vision trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05419713, a NA study of Vision, is actively recruiting participants, sponsored by University of Louisville.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

The ability to judge the locations of various objects from oneself during self-motion in the intermediate distance range (\~2-25m) is crucial for successful performance of activities of daily living, such as walking and driving. However, little is known about the mechanisms of visual space perception involved in judging distance, the focus of this project, in the planning and/or execution of self-motion in the natural 3D environment. The theoretical knowledge to be gained from this project will contribute to the scientific literature and provide insights into how eye and neurological defects could impair visual space perception, wayfinding, and mobility.

Conditions Studied

Interventions

  • OTHER Visual Stimuli for Space Perception

Study Locations (1)

Kentucky

  • University of Louisville - Louisville

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2021-09-30
Est. Completion 2025-06-30
Phase NA

Sponsor

University of Louisville

217 total trials

What the Registry Record Tells You About NCT05419713

The ClinicalTrials.gov registry entry for NCT05419713 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,058-participant average among 5 other Vision trials with a reported enrollment target (91% lower). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Vision appearing as the primary indexed condition, and to 1 intervention - of which Visual Stimuli for Space Perception is the first listed.

NCT05419713 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT05419713 about?

NCT05419713 is a clinical study titled "Intermediate Visual Space Perception". The ability to judge the locations of various objects from oneself during self-motion in the intermediate distance range (\~2-25m) is crucial for successful performance of activities of daily living, such as walking and driving. However, little is known about the mechanisms of visual space perceptio...

What is the current status of trial NCT05419713?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2021-09-30. Estimated completion is 2025-06-30.

What conditions does trial NCT05419713 study?

This clinical trial studies the following conditions: Vision.

What interventions are being tested in trial NCT05419713?

The interventions under investigation include: Visual Stimuli for Space Perception (OTHER).

Who is sponsoring clinical trial NCT05419713?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05419713 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vision

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.